|
Build Your Online Product Catalogs?
Product Name: |
Neocide® Tris (hydroxymethyl) Aminomethane
|
Supply Ability: |
|
Related proudcts |
tris hydroxymethyl a, cardiac marker test, |
Specifications |
1 |
Price Term: |
|
Port of loading: |
|
Minimum Order |
|
Unit Price: |
|
|
Good's buffer has the following characteristics: 1. High water solubility; 2. Low cell membrane permeability; 3. stable acid-base dissociation constant; 4. Low metal chelating capacity; 5. High chemical stability; 6. Low absorption spectra in ultraviolet and visible region;7. Low salt effect; 8. Easy to make high purity salt. They are essential raw materials for in vitro diagnostics reagents in the process of production.
NeoCide&©|174; Tris (Hydroxymethyl) Aminomethane For IVD Trimethylol aminomethane, also known as tris hydroxymethyl aminomethane, tromethamine, ammonium bradyarrhythmic acid, the product is white crystal, soluble in water, no pungent odor. Tris hydroxymethyl is generally known as the second generation of good's buffer co***red with the traditional good's buffer, the solubility and stability are better.
NeoCide&©|174; Tris HCl For IVD Tris HCl, trihydroxymethylaminomethane hydrochloride, also known as trihydroxyaminomethane hydrochloride, is a white crystal, soluble in water and free of impurities pungent odor. Tris HCl is commonly known as the second generation of good's buffer, and co***red with the traditional good's buffer, the solubility and stability are better. Features of Tris Aminomethane Tris aminomethane is an organic compound with the chemical formula C4H11NO3 and white crystalline particles. Can be used as biological buffer; used to prepare buffers for gel electrophoresis. As an alkaline drug, it is used for the correction of acidosis without causing an increase in carbon dioxide retention. |
Company: |
Hainan Medikament Trading Co., Ltd
|
Contact: |
medical ivd |
Address: |
6-A-502, Baoyuanhuayuan, Xiuyingdadao-18, Xiuyingqu, Haikou, 572000, Hainan, P.R. China |
Postcode: |
|
Tel: |
16687998712 |
Fax: |
|
E-mail: |
|
|
|
|